Key result
Despite minor antigenic subtype differences, a single inoculation with Mass or non-Mass vaccines could not protect chickens against the MV IBS037A/2014 and QX-like IBS130/2015 strains.
Why the study?
The antigenic relatedness and efficacy of infectious bronchitis virus vaccines against predominant Malaysian variant and QX-like field strains in chickens were not well characterized.
Does a single vaccination with Mass H120, K2, or 4/91 IBV strains prevent disease from Malaysian variant and QX-like IBV strains in SPF chickens?
Does a single vaccination with Mass H120, K2, or 4/91 IBV strains prevent disease from Malaysian variant and QX-like IBV strains in SPF chickens?
A single dose of commercial IBV vaccines (Mass H120, K2, 4/91) fails to protect chickens against the predominant Malaysian variant and QX-like IBV strains.
Answers are grounded in this paper and cite their sources.
Current IBV vaccines may not protect against Malaysian variants in poultry; leaves open the need for updated strain-matched formulations.
BACKGROUND: The predominant infectious bronchitis virus (IBV) strains detected in chickens in Malaysia are the Malaysian variant (MV) and QX-like, which are associated with respiratory distress, nephropathy, and high mortality. On the other hand, the antigenic relatedness and efficacy of IBV vaccines against these 2 field IBV strains are not well characterized. OBJECTIVES: This study aimed to determine the antigen relatedness and efficacy of different IB vaccine strains against a challenge with MV and QX-like strains. METHODS: The antigen relatedness and the ability of different IB vaccine strains in conferring protection against MV and QX-like were assessed based on the clinical signs, macroscopic lesions, and ciliary activity. RESULTS: The MV strain IBS037A/2014 showed minor antigenic subtype differences with the vaccine virus Mass H120 and 4/91 strains but showed major antigenic subtype differences with the K2 strain. The Malaysian QX-like strain IBS130/2015 showed major antigenic subtype differences with the MV strain IBS037A/2014 and the vaccine strains except for K2. Chickens vaccinated once with Mass (H120) or with non-Mass (4/91 and K2) developed antibody responses with the highest antibody titer detected in the groups vaccinated with H120 and 4/91. The mean ciliary activities of the vaccinated chickens were between 56 to 59% and 48 to 52% in chickens challenged with IBS037A/2014 and IBS130/2015, respectively. The vaccinated and challenged birds showed mild to severe lesions in the lungs and kidneys. CONCLUSIONS: Despite the minor antigenic subtype differences, a single inoculation with Mass or non-Mass vaccines could not protect against the MV IBS037A/2014 and QX-like IBS130/2015.
No takes yet. Share an insight, caveat, or question.
Ismail et al. (2020) studied Infectious bronchitis virus (IBV) infection. Single vaccination with Mass (H120) or non-Mass (4/91 and K2) IBV strains was evaluated on Protection against MV and QX-like strains based on clinical signs, macroscopic lesions, and ciliary activity. Despite minor antigenic subtype differences, a single inoculation with Mass or non-Mass vaccines could not protect chickens against the MV IBS037A/2014 and QX-like IBS130/2015 strains.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: